BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $338,433 | -38.9% | 8,344 | -3.3% | 0.11% | -60.3% |
| Q2 2022 | $554,000 | -49.7% | 8,631 | -37.0% | 0.28% | -60.0% |
| Q3 2021 | $1,101,000 | +58.0% | 13,693 | +58.1% | 0.69% | +9.3% |
| Q2 2021 | $697,000 | +184.5% | 8,659 | +198.7% | 0.63% | +43.4% |
| Q1 2021 | $245,000 | -64.0% | 2,899 | -67.2% | 0.44% | +49.3% |
| Q3 2018 | $680,000 | -30.6% | 8,826 | -41.4% | 0.30% | +24.4% |
| Q1 2018 | $980,000 | +4.9% | 15,067 | +4.3% | 0.24% | -12.8% |
| Q4 2017 | $934,000 | +86.1% | 14,446 | +80.6% | 0.27% | +92.3% |
| Q3 2017 | $502,000 | +112.7% | 8,000 | +105.1% | 0.14% | +73.2% |
| Q2 2017 | $236,000 | -57.4% | 3,900 | -68.8% | 0.08% | -71.8% |
| Q4 2016 | $554,000 | +10.6% | 12,500 | +2.5% | 0.29% | -13.1% |
| Q1 2016 | $501,000 | +84.9% | 12,200 | +71.8% | 0.34% | +59.5% |
| Q4 2015 | $271,000 | – | 7,100 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |